- BVI announces Virtuoso®, its first dual-function phaco-vitrectomy system designed to deliver advanced control, efficiency, and versatility for both cataract and vitreoretinal surgery.
- European debut planned for 2025 Global ophthalmic congresses in Europe (Euretina and ESCRS).
Waltham, Mass., September 3, 2025 – BVI, a leading global ophthalmic device company dedicated to sitting at the forefront of advancements in eye surgery, today announced the European market unveiling of its innovative phaco-vitrectomy surgical platform, Virtuoso®, a dual-function system designed for both cataract and vitreoretinal procedures. Lees verder







International
Brasil
Danmark
Deutschland
España
France
Italia
日本
Nederland
Norge
Suomi
Sverige
United States
United Kingdom